These data revealed an as‐yet unknown and critical role of Trip13 in the regulation of the insulin/Akt signaling pathway and downstream lipid metabolism in HCC cells, suggesting that Trip13‐KD‐dependent Akt activation during interphase was required for the mitotic defects observed in HCC cells. This evidence concerns the gene AKT1 and hepatocellular carcinoma.